Issue 25 of Multiple Myeloma Research Review. Highlights include: Induction VCD. Prediction of outcome in newly diagnosed myeloma Final...
Myeloma NZ
Cancer Society calls for major changes to save lives
The Cancer Society is calling for major changes to cancer services to save lives. It says 2,500 more New Zealanders would have survived cancer if...
Newsletter: February 2018
Happy New Year & greetings to you all Patient seminars: save the date Auckland on 28 February at North Shore Hospital Auditorium Wellington on 8...
You’re invited to a patient seminar – Wellington
INVITATION Patient Seminar: CAR T-Cell Therapy: a New Frontier in Blood Cancer Treatment Presented by Dr Rob Weinkove on 8 March, 5.30-7pm at...
You’re invited to a patient seminar – Auckland
INVITATION Patient Seminar: What's New in Myeloma Treatment: a New Zealand Perspective with...
Multinational Clinical Study
Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory...
Research Review: Multiple Myeloma – Issue 24
Issue 24 of Multiple Myeloma Research Review. Highlights include: Is MRD the best predictor of response? ctDNA and risk of distant relapse....
Tell us how we can help
We're keen to know how Myeloma New Zealand can help you. What you'd like to hear about on the website? What support you feel would be useful? We'd...
FDA Grants BCMA CAR T-Cell Therapy Breakthrough Designation in Myeloma
The FDA has granted bb2121 a breakthrough therapy designation for previously treated patients with relapsed/refractory multiple myeloma, according...
You’re invited to a patient seminar
INVITATION Patient Seminar:  Improving Survival in Multiple Myeloma Dr. Henry Chan from North Shore Hospital will be speaking at our patient seminar...
Newsletter: November 2017
Greetings SAVE THE DATE: Patient Seminar 29 November, 5:30 – 7.30pm I’m delighted to advise that Dr Henry Chan from North Shore Hospital has agreed...
Daratumumab approved for use on NHS in Scotland
Patients in Scotland will now be able to access the new myeloma treatment, daratumumab (Darzalex®) on the NHS, after the Scottish Medicines...